Because Glycogen synthase-3-β (GSK3β) contributes to the tau hyperphosphorylation and Aβ generation [34,35,36] in the pathogenesis of AD, we therefore investigated the mRNA expression levels of GSK3β in the brains of CCI-injured and compared them to that of naïve rats. This evidence concerns the gene MAPT and Alzheimer disease.